Changes in inflammatory conditions may be another pathway through which astaxanthin can improve metabolic changes induced by obesity, as astaxanthin inhibits the activation of the transcriptional factor of NF-κB to reduce the actions of pro-inflammatory cytokines [55]. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.